SERPING1 and hereditary angioedema: A nano-filtered plasma-derived C1-INH (pdC1-INH) concentrate was authorized by the European Medicines Agency (EMA) in 2011 for the treatment of HAE in adults at a dose of 1000 Units i.v. as soon as HAE attacks appeared and repeated after an hour if necessary [23].